Novartis Institutes for BioMedical Research Global Scholars Program 2021
Novartis Institutes for BioMedical Research (NIBR) have invited Boston University, as one of a select group of international institutions, to participate in their NIBR Global Scholars Program 2021 (Kerberos log-in required). The program will provide BU faculty investigators with access to disease area drug-hunting and translational research expertise. Selected proposals, not funded by traditional grant support, will receive up to $1 million over three years.
Initial two-page, non-confidential pre-proposals must be submitted for review by BU Industry Engagement and Technology Development by Monday, May 10, prior to the NIBR submission (deadline of Friday, May 14). Pre-proposals should be submitted for review using a web form on the Industry Engagement website (Kerberos log-in required).
Proposals focused in any of the following areas are encouraged:
Disease Areas
- Autoimmunity, Transplantation & Inflammation
- Cardiovascular and Metabolic
- Immuno-Oncology
- Musculoskeletal Diseases
- Neurosciences
- Oncology
- Ophthalmology
- Tropical Diseases
- Additional Disease Areas
Platform Technologies
- Analytical Sciences & Imaging
- Biologics
- Cell and Gene Therapy
- Chemical and Biological Therapies
- Discovery Chemistry
- PK Sciences and Preclinical Safety
Download the full list of scientific needs on the program webpage.